As a 67‑year‑old man receiving weekly intramuscular injections of Testoviron depot (testosterone enanthate) 175 mg, what additional supplements should I take to optimize my health?

Supplementation for a 67-Year-Old Man on Weekly Testosterone Injections

You should focus on calcium (1,200 mg daily) and vitamin D (800–1,000 IU daily) supplementation to protect bone health, monitor your hematocrit every 3–6 months with dose reduction or phlebotomy if it exceeds 54%, and ensure cardiovascular risk factors are optimally managed—but avoid adding supplements for energy, mood, or cognitive enhancement, as testosterone provides no meaningful benefit in these domains.

---

Core Supplementation Requirements

Bone Health Protection

• Calcium supplementation at 1,200 mg daily is recommended for men over 65 years receiving testosterone therapy, as this age group has increased bone turnover and testosterone can modestly improve bone mineral density (3.2% at lumbar spine, 1.4% at femoral neck). 1
• Vitamin D at 800–1,000 IU daily should be combined with calcium to maintain skeletal health, particularly in older adults on testosterone replacement. 2, 1
• Weight-bearing exercise should be performed regularly alongside supplementation to maximize bone protection. 2

---

Critical Monitoring and Safety Considerations

Hematocrit Surveillance (Your Highest Priority)

• Injectable testosterone at 175 mg weekly carries a 43.8% risk of erythrocytosis, far exceeding the 15.4% risk with transdermal preparations. 1, 3
• Check hematocrit every 3–6 months; if it rises above 54%, testosterone must be withheld immediately and therapeutic phlebotomy considered. 1, 3
• Elevated hematocrit increases blood viscosity and can exacerbate coronary, cerebrovascular, and peripheral vascular disease—particularly dangerous at age 67. 1
• Your weekly 175 mg dose is above standard guidelines (50–100 mg weekly or 100–200 mg every 2 weeks), which increases your erythrocytosis risk. 1, 3

Cardiovascular Risk Management

• Testosterone therapy in men ≥65 years with pre-existing cardiovascular risk showed no increase in major adverse cardiac events or stroke in the 2023 TRAVERSE trial, but optimal management of underlying risk factors remains essential. 1
• Ensure your blood pressure, lipid profile, and diabetes control (if applicable) are optimized, as testosterone may modestly decrease HDL cholesterol. 1, 4
• Target mid-normal testosterone levels (450–600 ng/dL) measured midway between injections to minimize adverse effects while maintaining efficacy. 1, 3

Prostate Monitoring

• PSA and digital rectal examination should be performed every 6–12 months in men over 40 receiving testosterone therapy. 1, 3
• Refer to urology if PSA rises >1.0 ng/mL in the first 6 months or >0.4 ng/mL per year thereafter. 1

---

What NOT to Supplement

Energy, Mood, and Cognitive Supplements Are Ineffective

• Testosterone therapy produces little to no clinically meaningful improvement in energy, vitality, physical functioning, depressive symptoms, or cognition, even in confirmed hypogonadism. 1
• The effect size for fatigue/energy improvement is negligible (standardized mean difference 0.17), well below clinical significance. 1
• Do not waste money on supplements marketed for "brain fog," low energy, or mood enhancement in the context of testosterone therapy—the hormone itself provides no benefit in these domains, and adding supplements will not change this. 1

Avoid Unnecessary Supplements

• DHEA-S supplementation is not indicated, as it does not aid in diagnosing or managing hypogonadism and provides no additional benefit when testosterone is already being replaced. 1
• Vitamin D and CRP testing are not part of standard hypogonadism monitoring unless specific clinical indications exist. 1

---

Expected Benefits of Your Current Therapy

Sexual Function (Primary Benefit)

• Testosterone therapy yields a small but statistically significant improvement in sexual function and libido (standardized mean difference 0.35), which is the primary evidence-based indication. 1
• Modest quality-of-life improvements are confined to sexual function domains, with no broader health-related gains. 1

Metabolic Effects

• Potential improvements in fasting glucose, insulin resistance, triglycerides, and HDL cholesterol may occur, though effects are modest. 1
• Weight loss through calorie restriction and regular exercise can further enhance testosterone levels and metabolic health in men with obesity-related hypogonadism. 1

---

Dose Optimization Considerations

Your Current Dose May Be Too High

• Standard dosing for testosterone enanthate is 50–100 mg weekly or 100–200 mg every 2 weeks, not 175 mg weekly. 1, 3
• Your dose creates more frequent supraphysiologic peaks (occurring 2–5 days post-injection), which directly increases erythrocytosis risk to approximately 44%. 1, 3
• If your testosterone levels exceed 600 ng/dL at mid-cycle (days 3–4 after injection), dose reduction to 100 mg weekly or 150 mg every 2 weeks should be considered to minimize adverse effects while maintaining efficacy. 1, 3

Formulation Alternatives

• Switching to transdermal testosterone gel (40.5 mg daily) would reduce erythrocytosis risk from 44% to 15% by providing more stable day-to-day levels without supraphysiologic peaks. 1, 3
• The primary disadvantage of gel is higher cost (~$2,135/year vs ~$156/year for injections), but this may be justified if erythrocytosis develops. 1, 3

---

Common Pitfalls to Avoid

• Do not ignore mild erythrocytosis (hematocrit 50–52%) at your age, as even modest elevations increase thrombotic risk in older adults with cardiovascular disease. 1
• Do not continue full-dose testosterone if hematocrit exceeds 54%—this is an absolute indication to withhold therapy. 1
• Do not expect meaningful improvements in energy, mood, or cognitive function from testosterone therapy, as these benefits are not supported by evidence. 1
• Do not add supplements for "anti-aging" or "vitality" purposes, as age-related testosterone decline is not considered a disease requiring treatment beyond confirmed hypogonadism with specific symptoms. 1

---

Practical Summary Algorithm

1. Start calcium 1,200 mg + vitamin D 800–1,000 IU daily for bone protection. 2, 1
2. Check hematocrit every 3–6 months; withhold testosterone if >54% and consider phlebotomy. 1, 3
3. Measure testosterone levels midway between injections (days 3–4 after your weekly dose); target 450–600 ng/dL. 1, 3
4. If testosterone >600 ng/dL or hematocrit >52%, reduce dose to 100 mg weekly or switch to transdermal gel. 1, 3
5. Monitor PSA and perform digital rectal exam every 6–12 months. 1, 3
6. Optimize cardiovascular risk factors (blood pressure, lipids, diabetes control). 1
7. Avoid supplements for energy, mood, or cognition—they provide no benefit. 1